001     131816
005     20240229105015.0
024 7 _ |a 10.1002/ijc.31146
|2 doi
024 7 _ |a pmid:29114875
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:28710821
|2 altmetric
037 _ _ |a DKFZ-2018-00111
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a van Duijnhoven, Fränzel J B
|0 0000-0001-8367-2352
|b 0
245 _ _ |a Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations.
260 _ _ |a Bognor Regis
|c 2018
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1521453513_12159
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Evidence from in vivo, in vitro and ecological studies are suggestive of a protective effect of vitamin D against pancreatic cancer (PC). However, this has not been confirmed by analytical epidemiological studies. We aimed to examine the association between pre-diagnostic circulating vitamin D concentrations and PC incidence in European populations. We conducted a pooled nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) and the Nord-Trøndelag Health Study's second survey (HUNT2) cohorts. In total, 738 primary incident PC cases (EPIC n = 626; HUNT2 n = 112; median follow-up = 6.9 years) were matched to 738 controls. Vitamin D [25(OH)D2 and 25(OH)D3 combined] concentrations were determined using isotope-dilution liquid chromatography-tandem mass spectrometry. Conditional logistic regression models with adjustments for body mass index and smoking habits were used to estimate incidence rate ratios (IRRs) and 95% confidence intervals (95%CI). Compared with a reference category of >50 to 75 nmol/L vitamin D, the IRRs (95% CIs) were 0.71 (0.42-1.20); 0.94 (0.72-1.22); 1.12 (0.82-1.53) and 1.26 (0.79-2.01) for clinically pre-defined categories of ≤25; >25 to 50; >75 to 100; and >100 nmol/L vitamin D, respectively (p for trend = 0.09). Corresponding analyses by quintiles of season-standardized vitamin D concentrations also did not reveal associations with PC risk (p for trend = 0.23). Although these findings among participants from the largest combination of European cohort studies to date show increasing effect estimates of PC risk with increasing pre-diagnostic concentrations of vitamin D, they are not statistically significant.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Jenab, Mazda
|b 1
700 1 _ |a Hveem, Kristian
|b 2
700 1 _ |a Siersema, Peter D
|b 3
700 1 _ |a Fedirko, Veronika
|b 4
700 1 _ |a Duell, Eric J
|0 0000-0001-5256-0163
|b 5
700 1 _ |a Kampman, Ellen
|b 6
700 1 _ |a Halfweeg, Anouk
|b 7
700 1 _ |a van Kranen, Henk J
|b 8
700 1 _ |a van den Ouweland, Jody M W
|b 9
700 1 _ |a Weiderpass, Elisabete
|b 10
700 1 _ |a Murphy, Neil
|b 11
700 1 _ |a Langhammer, Arnulf
|b 12
700 1 _ |a Ness-Jensen, Eivind
|b 13
700 1 _ |a Olsen, Anja
|b 14
700 1 _ |a Tjønneland, Anne
|b 15
700 1 _ |a Overvad, Kim
|b 16
700 1 _ |a Cadeau, Claire
|b 17
700 1 _ |a Kvaskoff, Marina
|b 18
700 1 _ |a Boutron-Ruault, Marie-Christine
|b 19
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 20
|u dkfz
700 1 _ |a Kühn, Tilman
|0 0000-0001-7702-317X
|b 21
700 1 _ |a Boeing, Heiner
|b 22
700 1 _ |a Trichopoulou, Antonia
|b 23
700 1 _ |a Kotanidou, Anastasia
|b 24
700 1 _ |a Kritikou, Maria
|b 25
700 1 _ |a Palli, Domenico
|0 0000-0002-5558-2437
|b 26
700 1 _ |a Agnoli, Claudia
|b 27
700 1 _ |a Tumino, Rosario
|b 28
700 1 _ |a Panico, Salvatore
|b 29
700 1 _ |a Matullo, Giuseppe
|b 30
700 1 _ |a Peeters, Petra
|b 31
700 1 _ |a Brustad, Magritt
|b 32
700 1 _ |a Olsen, Karina Standahl
|b 33
700 1 _ |a Lasheras, Cristina
|b 34
700 1 _ |a Obón-Santacana, Mireia
|b 35
700 1 _ |a Sánchez, María-José
|b 36
700 1 _ |a Dorronsoro, Miren
|b 37
700 1 _ |a Chirlaque, Maria-Dolores
|b 38
700 1 _ |a Barricarte, Aurelio
|b 39
700 1 _ |a Manjer, Jonas
|b 40
700 1 _ |a Almquist, Martin
|b 41
700 1 _ |a Renström, Frida
|b 42
700 1 _ |a Ye, Weimin
|0 0000-0002-6859-4648
|b 43
700 1 _ |a Wareham, Nick
|b 44
700 1 _ |a Khaw, Kay-Tee
|b 45
700 1 _ |a Bradbury, Kathryn E
|0 0000-0003-3345-7333
|b 46
700 1 _ |a Freisling, Heinz
|b 47
700 1 _ |a Aune, Dagfinn
|b 48
700 1 _ |a Norat, Teresa
|b 49
700 1 _ |a Riboli, Elio
|b 50
700 1 _ |a Bueno-de-Mesquita, H B As
|b 51
773 _ _ |a 10.1002/ijc.31146
|g Vol. 142, no. 6, p. 1189 - 1201
|0 PERI:(DE-600)1474822-8
|n 6
|p 1189 - 1201
|t International journal of cancer
|v 142
|y 2018
|x 0020-7136
909 C O |o oai:inrepo02.dkfz.de:131816
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 0000-0001-7702-317X
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2015
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21